bluebird bio (BLUE) – Trading Halts
-
bluebird bio (BLUE) Announces FDA Approval of LYFGENIA for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
-
bluebird bio (BLUE) Halted, News Pending
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BLUE Stock Lookup